Gene · 21
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity. | Hum Genet | 2022 | 34889978 | PubTator, text mining | PubMed |
| Salinomycin as a potent anticancer stem cell agent: State of the art and future directions. | Med Res Rev | 2022 | 34786735 | PubTator, text mining | PubMed |
| Inhibitor-Resistant Mutants Give Important Insights into Candida albicans ABC Transporter Cdr1 Substrate Specificity and Help Elucidate Efflux Pump Inhibition. | Antimicrob Agents Chemother | 2022 | 34780272 | PubTator, text mining | PubMed |
| Possible association between a polymorphism of EPAS1 gene and persistent pulmonary hypertension of the newborn: a case-control study. | J Pediatr (Rio J) | 2022 | 34678164 | PubTator, text mining | PubMed |
| Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019. | Cytotherapy | 2022 | 34656419 | PubTator, text mining | PubMed |
| Verification of immunology-related genetic associations in BPD supports ABCA3 and five other genes. | Pediatr Res | 2022 | 34465876 | PubTator, text mining | PubMed |
| Prevalence of monogenic disease in paediatric patients with a predominant respiratory phenotype. | Arch Dis Child | 2022 | 34134972 | PubTator, text mining | PubMed |
| Epidermal Growth Factor Receptor Mutation Mechanisms in Nonsmall Cell Lung Cancer by Transcriptome Sequencing. | Cancer Biother Radiopharm | 2022 | 34009009 | PubTator, text mining | PubMed |
| Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors. | Explor Target Antitumor Ther | 2021 | 36046141 | PubTator, text mining | PubMed |
| ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome. | Cancer Drug Resist | 2021 | 35582032 | PubTator, text mining | PubMed |
| A Natural Low Phytic Acid Finger Millet Accession Significantly Improves Iron Bioavailability in Indian Women. | Front Nutr | 2021 | 35402470 | PubTator, text mining | PubMed |
| Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis. | Front Pharmacol | 2021 | 35126134 | PubTator, text mining | PubMed |
| Identification of CDK1 as a candidate marker in cutaneous squamous cell carcinoma by integrated bioinformatics analysis. | Transl Cancer Res | 2021 | 35116276 | PubTator, text mining | PubMed |
| Gene Therapy Potential for Genetic Disorders of Surfactant Dysfunction. | Front Genome Ed | 2021 | 35098209 | PubTator, text mining | PubMed |
| Integrative Multi-Omics Analysis Reveals Candidate Biomarkers for Oral Squamous Cell Carcinoma. | Front Oncol | 2021 | 35096593 | PubTator, text mining | PubMed |
| Integrated Dissection of lncRNA-miRNA-mRNA Pairs and Potential Regulatory Role of lncRNA PCAT19 in Lung Adenocarcinoma. | Front Genet | 2021 | 35095999 | PubTator, text mining | PubMed |
| Combining Lovastatin and Minocycline for the Treatment of Fragile X Syndrome: Results From the LovaMiX Clinical Trial. | Front Psychiatry | 2021 | 35058813 | PubTator, text mining | PubMed |
| Channels and Transporters of the Pulmonary Lamellar Body in Health and Disease. | Cells | 2021 | 35011607 | PubTator, text mining | PubMed |
| Metaproteomics Approach and Pathway Modulation in Obesity and Diabetes: A Narrative Review. | Nutrients | 2021 | 35010920 | PubTator, text mining | PubMed |
| Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters. | Free Neuropathol | 2021 | 34977908 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/21/papers?page=22